LU82072A1 - Procede de granulation de la trans-d1-1-hydroxy-3-(1',1'-dimethylheptyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo(b,d)pyran-9-one(nabilone) - Google Patents

Procede de granulation de la trans-d1-1-hydroxy-3-(1',1'-dimethylheptyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo(b,d)pyran-9-one(nabilone) Download PDF

Info

Publication number
LU82072A1
LU82072A1 LU82072A LU82072A LU82072A1 LU 82072 A1 LU82072 A1 LU 82072A1 LU 82072 A LU82072 A LU 82072A LU 82072 A LU82072 A LU 82072A LU 82072 A1 LU82072 A1 LU 82072A1
Authority
LU
Luxembourg
Prior art keywords
nabilone
ethanol
trans
hydroxy
dimethyl
Prior art date
Application number
LU82072A
Other languages
English (en)
French (fr)
Inventor
J Conine
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU82072A1 publication Critical patent/LU82072A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
LU82072A 1979-03-09 1980-01-10 Procede de granulation de la trans-d1-1-hydroxy-3-(1',1'-dimethylheptyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo(b,d)pyran-9-one(nabilone) LU82072A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/019,810 US4195078A (en) 1979-03-09 1979-03-09 Nabilone granulation
US1981079 1979-03-09

Publications (1)

Publication Number Publication Date
LU82072A1 true LU82072A1 (fr) 1980-04-23

Family

ID=21795156

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82072A LU82072A1 (fr) 1979-03-09 1980-01-10 Procede de granulation de la trans-d1-1-hydroxy-3-(1',1'-dimethylheptyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo(b,d)pyran-9-one(nabilone)

Country Status (16)

Country Link
US (1) US4195078A (it)
EP (1) EP0015635A1 (it)
JP (1) JPS55133309A (it)
AU (1) AU531805B2 (it)
BE (1) BE881049A (it)
CA (1) CA1124178A (it)
CH (1) CH643840A5 (it)
DK (1) DK8080A (it)
FR (1) FR2450606A1 (it)
GB (1) GB2045080B (it)
IE (1) IE49243B1 (it)
IL (1) IL59098A (it)
IT (1) IT1193886B (it)
LU (1) LU82072A1 (it)
NZ (1) NZ192557A (it)
ZA (1) ZA80104B (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327080A (en) * 1981-07-13 1982-04-27 E. R. Squibb & Sons, Inc. Novel Bendroflumethiazide formulations and method
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
NZ211545A (en) * 1984-04-11 1987-09-30 Ici Australia Ltd Composition having particulate trace element suspended in matrix of solid polyethylene glycol
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4844908A (en) * 1986-11-27 1989-07-04 Duphar International Research B.V. Method of preparing tablets with clovoxamine fumarate and tablets thus prepared
EP0547796A1 (en) * 1991-12-17 1993-06-23 Konica Corporation Solid chemicals for processing silver halide photographic light-sensitive material
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US20020137802A1 (en) * 2000-09-28 2002-09-26 Travis Craig R. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
AU2003214226A1 (en) * 2002-03-18 2003-10-08 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
CA2845443A1 (en) * 2014-03-04 2015-09-04 Pharmascience Inc. Orally disintegrating tablet of nabilone and method of manufacturing

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR886435A (fr) * 1941-09-29 1943-10-14 Aiguille à tricoter perfectionnée
US3136692A (en) * 1961-06-30 1964-06-09 Strong Cobb Arner Inc Effervescent composition containing polyvinylpyrrolidone
DE1467792A1 (de) * 1965-05-21 1968-12-12 Brunnengraeber & Co Gmbh Dr Ch Sprengmittel fuer pharmazeutische Presslinge
CA885974A (en) * 1968-04-02 1971-11-16 R. Telfer William Ferrous fumarate capsule and preparation
IL32673A (en) * 1968-08-05 1973-11-28 Ciba Geigy Ag A granular material containing oily or liquid therapeutically usable furanosides and a process for its manufacture
US3632778A (en) * 1970-06-10 1972-01-04 Hoffmann La Roche Tablets containing l-dopa
NL7112288A (it) * 1970-09-16 1972-03-20
JPS5418330B2 (it) * 1973-03-16 1979-07-06
US3851032A (en) * 1973-04-23 1974-11-26 Sterling Drug Inc Process of preparing a solid fine crystalline paracetamol polymer complex composition
US3864492A (en) * 1973-08-01 1975-02-04 Abbott Lab Method of treating depression using 1,4{40 -dihydroxy-3-n-pentyl-6,6,9-trimethyl-6a,7,10,10a-tetra-hydrodibenzo{8 b,d{9 pyran
IE39678B1 (en) * 1973-11-05 1978-12-06 Lilly Co Eli A polymorphic form of a dibenzopyranone
US3920809A (en) * 1973-11-05 1975-11-18 Lilly Co Eli Dibenzo(b,d)pyranone dispersions
US3987188A (en) * 1973-11-05 1976-10-19 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as sedative drugs
US3953603A (en) * 1973-11-05 1976-04-27 Eli Lilly And Company Hexahydro-dibenzo[b,d,]pyran-9-ones as psychotropic, particularly anti-depressant drugs
US4024275A (en) * 1973-11-05 1977-05-17 Eli Lilly And Company Method of reducing elevated blood pressure with dihydroxy-hexahydrodibenzo(b,d)pyrans
US3944673A (en) * 1973-11-05 1976-03-16 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as analgesic drugs
AT329556B (de) * 1974-10-24 1976-05-25 Lilly Co Eli Verfahren zur herstellung einer neuen stabilen polymorphen kristallinen form von 1-hydroxy-3-(1',1'-dimethylheptyl)-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo(b,d)pyran-9-on
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087547A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones in treatment of glaucoma
US4088777A (en) * 1976-02-17 1978-05-09 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as anticonvulsant drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs

Also Published As

Publication number Publication date
IE49243B1 (en) 1985-09-04
AU531805B2 (en) 1983-09-08
IE800042L (en) 1980-09-09
FR2450606A1 (fr) 1980-10-03
IL59098A (en) 1983-09-30
IT8019114A0 (it) 1980-01-09
FR2450606B1 (it) 1983-04-15
ZA80104B (en) 1981-08-26
IT1193886B (it) 1988-08-31
CH643840A5 (fr) 1984-06-29
GB2045080A (en) 1980-10-29
NZ192557A (en) 1981-05-01
AU5455480A (en) 1980-09-11
GB2045080B (en) 1983-05-25
EP0015635A1 (en) 1980-09-17
JPS55133309A (en) 1980-10-17
BE881049A (fr) 1980-07-09
JPH0142923B2 (it) 1989-09-18
CA1124178A (en) 1982-05-25
DK8080A (da) 1980-09-10
IL59098A0 (en) 1980-05-30
US4195078A (en) 1980-03-25

Similar Documents

Publication Publication Date Title
LU82072A1 (fr) Procede de granulation de la trans-d1-1-hydroxy-3-(1',1'-dimethylheptyl)-6,6-dimethyl-6a,7,8,9,10,10a-hexahydrobenzo(b,d)pyran-9-one(nabilone)
CA2377909C (fr) Composition pharmaceutique contenant du fenofibrate et prodede de preparation
US5417982A (en) Controlled release of drugs or hormones in biodegradable polymer microspheres
EP0050551B1 (fr) Nouveau médicament à base d'amino-2 trifluorométhoxy-6 benzothiazole
EP0673245B1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofene et son procede de preparation
WO1997004749A1 (fr) Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
WO2011010324A1 (en) Oral pharmaceutical composition of rasagiline and process for preparing thereof
KR20070026187A (ko) 2개 이상의 활성 물질을 함유하는 주사용 멸균 약제학적제형
FR2571617A1 (fr) Procede pour la microencapsulation par separation de phases de substances medicamenteuses hydrosolubles
WO2003039513A1 (de) Verfahren zur bildung von profenkristallen
FR2819720A1 (fr) Nouveaux comprimes de fenofibrate
DE202007019385U1 (de) Pharmazeutische Zusammensetzungen, umfassend Clopidogrel
LU81799A1 (fr) Solution stable d'erythromycine
KR100321617B1 (ko) 항진균제와 유기산류의 공융혼합물 및 이를 함유하는 약학적 제제
EP0483320B1 (fr) Compositions pharmaceutiques du type a liberation prolongee destinees a l'administration par voie orale et leur procede de preparation
EP0908177B1 (en) Procedure to form pharmaceutical compositions in spherical pills or granules of controlled and sustained action that contain as active agent Bromazepam and pharmaceutical compositions obtained by said procedure
DD220225A5 (de) Verfahren zur herstellung einer festkoerperdispersion von chlorthalidon
FR2547730A1 (fr) Medicament hypolipidemiant contenant comme ingredient actif la d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one ou un de ses sels d'addition d'acides acceptables en pharmacie
FR2476485A1 (fr) Nouveau procede d'enrobage d'au moins un principe actif medicamenteux, les nouveaux medicaments ainsi obtenus, et les compositions les renfermant
FR2616068A1 (fr) Procede de stabilisation des principes actifs de produits vegetaux et les compositions pharmaceutiques renfermant lesdits principes actifs stabilises
EP0116182A1 (fr) Procédé de préparation d'acide p-butoxyphénylacéthydroxamique à l'état finement divisé
CH640137A5 (fr) Composition pharmaceutique contenant de la s-adenosyl-l-homocysteine.
BE819863A (fr) Compositions d'antibiotiques du type virginiamycine pour administration orale.
WO2005089711A2 (de) Pharmazeutische formulierung mit unvermahlenem flutamid
JPH1192311A (ja) 無定形ベンゾイルウレア及びそれを有効成分とする温血動物の寄生虫防除剤